Top compounds associated with response to LCORL


Feature Type Standardized
Nominal ANOVA
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.095 0.006
mRNA SN-38 CTRPv2 pan-cancer AAC 0.1 0.006
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.083 0.006
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.089 0.006
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.006
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.094 0.007
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.091 0.007
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.007
mRNA SID 26681509 CTRPv2 pan-cancer AAC 0.1 0.007
mRNA Topotecan CTRPv2 pan-cancer AAC 0.088 0.007
Download CSV